Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy
Document Type
Journal Article
Publication Date
2012
Journal
Stroke
Volume
43
Issue
4
Inclusive Pages
952-957
APA Citation
Rossouw, J., Johnson, K., Pettinger, M., Cushman, M., & Sandset, P. (2012). Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke, 43 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/3155
COinS